# Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer

> **NCT06387368** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Xi'an Jiaotong University** · enrollment: 488 (estimated)

## Conditions studied

- Pancreatic Cancer Non-resectable

## Interventions

- **DRUG:** Huaier Granule
- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT06387368
- **Lead sponsor:** Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-05
- **Primary completion:** 2028-03
- **Final completion:** 2028-08
- **Target enrollment:** 488 (ESTIMATED)
- **Last updated:** 2024-04-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06387368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06387368, "Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06387368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*